A carregar...
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer. The prognostic signature could be reliable to stratify LUAD patients according to risk, which helps the management of the systematic treatments. In this study, a systematic and reliable immune signature was performed...
Na minha lista:
| Publicado no: | J Transl Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060601/ https://ncbi.nlm.nih.gov/pubmed/32143735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02286-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|